Continuous Glucose Monitoring bei Schwangeren mit Typ-1-Diabetes mellitus – Vorstellung der CONCEPTT-Studie und Kommentar

Helmut Kleinwechter

doi:10.1055/s-0043-124689

Diabetologie und Stoffwechsel, Table of Contents

Diabetologie und Stoffwechsel 2018; 13(01): 32-34
DOI: 10.1055/s-0043-124689

Leserbrief

Continuous Glucose Monitoring bei Schwangeren mit Typ-1-Diabetes mellitus – Vorstellung der CONCEPTT-Studie und Kommentar

Helmut Kleinwechter

Abstract

Full Text

References

Literatur
1 Klein F. Schwanger und Typ 1? CGM anbieten! Kontinuierliches Blutzuckermonitoring senkt Risiken für Neugeborene. diabetes zeitung 2017; 2: 8
2 Hil/aerzteblatt.de Kontinuierliche Glukosemessung vermindert Schwangerschaftskomplikationen bei Typ-1-Diabetikerinnen. https://www.aerzteblatt.de/nachrichten/79473/Kontinuierliche-Glukosemessung-vermindert-Schwangerschaftskomplikationen-bei-Typ-1-Diabetikerinnen Zugriff am 30.09.2017
3 Polsky S, Garcetti R. CGM, Pregnancy, and Remote Monitoring. Diabetes Technol Ther 2017; 19 (Suppl. 03) S49-S59
4 Feig D, Donovan K, Corcoy R. et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 2017;
5 Petrie J, Peters A, Bergenstal R. et al. Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care 2017;
6 Danne T, Nimri R, Battelino T. et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017; 40: 1631-1640
7 Garg S, Polsky S. Continuous glucose monitoring in pregnant women with type 1 diabetes. Lancet 2017;
8 Beck R, Riddlesworth TRuedy K. et al. for the DIAMOND Study Group. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trail. JAMA 2017; 317: 371-378
9 Lind M, Polonsky W, Hirsch I. et al. Continuous Glucose Monitoring vs. Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections. The GOLD Randomized Clinical Trial. JAMA 2017; 317: 379-387